73 filings
Page 4 of 4
6-K
noi5qfsvhte
18 Mar 21
PainReform Provides Year-End Business Update and Reports Progress Towards
10:36am
6-K
th1wcz6wcxqa ox
9 Mar 21
PainReform Announces $6.0 Million Private Placement
4:15pm
6-K
p60rs26hvvrznd8z94y7
1 Mar 21
Report of Foreign Private Issuer
7:00am
6-K
52k9zo iz572b9epr
23 Feb 21
Report of Foreign Private Issuer
4:30pm
6-K
5cq5rw0
19 Jan 21
Extraordinary General Meeting of Shareholders
4:35pm
6-K
llvnxo
6 Jan 21
PainReform Appoints Rita Keynan as Vice President of Pharmaceutical Operations
9:00am
6-K
jmmjni0eg kb762hxmq
5 Jan 21
Investor Presentation January 2021
4:15pm
6-K
w3k xszuym
4 Jan 21
PainReform Announces Appointment of Lotus Clinical Research as CRO for Phase 3 Clinical Trial of PRF-110
4:16pm
6-K
ivky2 8ylsnv6m5x
25 Nov 20
PainReform Appoints Senior Pharmaceutical Executive and Finance Veteran Ilan Hadar as Chief Executive Officer
10:08am
6-K
oo5cu03hmxhvgpku0ow
13 Nov 20
Report of Foreign Private Issuer
6:09am
6-K
thk2sim48yfji1zj3
9 Nov 20
PainReform Welcomes Senior Pharmaceutical Executive and Venture Capitalist Augustine Lawlor to Board of Directors
10:30am
6-K
c8xvp np8grvswt1eb
19 Oct 20
PainReform Highlights Surgical Advantages of PRF-110
1:37pm
6-K
se8of
30 Sep 20
Condensed Financial Statements
4:32pm